Disclosures for "A Prospective, Observational Study to Evaluate the Long-term Safety, Including Cardiovascular Safety, of Fremanezumab in Patients with Migraine in Routine Clinical Practice"
-
Dr. Kahan has received personal compensation for serving as an employee of Teva Pharmaceutical Industries Ltd. Dr. Kahan has stock in Teva Pharmaceutical Industries Ltd. .
-
Lynda Krasenbaum has received personal compensation for serving as an employee of Teva Pharmaceuticals.
-
Dr. Braverman has nothing to disclose.
-
Dr. Barash has received personal compensation for serving as an employee of Teva. Dr. Barash has stock in Teva.
-
Dr. Colilla has received personal compensation for serving as an employee of Teva Pharmaceuticals. Dr. Colilla has stock in Teva Pharmaceuticals.
-
Dr. Jennissen has received personal compensation for serving as an employee of Teva Pharmaceuticals International GmbH.
-
Ms. Nellailingam has nothing to disclose.
-
Miss Rainville has received personal compensation for serving as an employee of Teva Pharmaceuticals. Miss Rainville has stock in Teva Pharmaceuticals.
-
Dr. Ramirez Campos has received personal compensation for serving as an employee of teva.
-
Mrs. Frain has received personal compensation for serving as an employee of Teva. Mrs. Frain has stock in Teva.
-
Dr. Akcicek has received personal compensation for serving as an employee of Teva Pharmaceuticals.
-
Dr. Jm has nothing to disclose.